Prevalence and predictors of left ventricular diastolic dysfunction in a hispanic patient population

International Journal of Angiology

Volumn 22, Issue 4, 2013, Pages 229-234

  Castro, Carlos E Rodríguez ^a   Lyapin, Alexander ^a   Pattathan, Mithun ^a   Negrin, José ^a   Mukherjee, Debabrata ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

diabetes complications; Hispanic patient population; left ventricular dysfunction; prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERTENSION; KIDNEY FAILURE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TISSUE DOPPLER IMAGING; UNITED STATES; VULNERABLE POPULATION;

EID: 84888025103     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0033-1353240     Document Type: Article

References (16)

1. Aurigemma G. P., Gaasch W. H. Clinical practice. Diastolic heart failure. N Engl J Med: 2004; 351 11 1097 1105
2. Bin-Jaliah I., Ammar H. I., Mikhailidis D. P., et al. Cardiac adaptive responses after hypoxia in an experimental model. Angiology: 2010; 61 2 145 156
3. Zile M. R., Wexler L., Gaasch W. H. Pathophysiology of diastolic heart failure. Available at: http://www.uptodate.com/contents/pathophysiology-of- diastolic-heart-failure
4. Andersson C., Gislason G. H., Weeke P., et al. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol: 2010; 9 3
5. Liu J. E., Palmieri V., Roman M. J., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol: 2001; 37 7 1943 1949
6. Störk T., Möckel M., Danne O., Völler H., Eichstädt H., Frei U. Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease. Cardiovasc Drugs Ther: 1995; 9 03 533 537
7. Kuznetsova T., Herbots L., López B., et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail: 2009; 2 2 105 112
8. Fischer M., Baessler A., Hense H. W., et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J: 2003; 24 4 320 328
9. Kane G. C., Karon B. L., Mahoney D. W., et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA: 2011; 306 8 856 863
10. Vasan R. S., Larson M. G., Benjamin E. J., Evans J. C., Reiss C. K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol: 1999; 33 7 1948 1955
11. Luchner A., Bröckel U., Muscholl M., et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res: 2002; 53 3 720 727
12. Jarnert C., Landstedt-Hallin L., Malmberg K., et al. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study. Eur J Heart Fail: 2009; 11 1 39 47
13. Poulsen M. K., Henriksen J. E., Dahl J., et al. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging: 2010; 3 1 24 31
14. National Diabetes Information Clearinghouse (NDIC). National Diabetes Statistics, 201. Available at: http://diabetes.niddk.nih.gov/index.aspx
15. von Bibra H., Hansen A., Dounis V., Bystedt T., Malmberg K., Rydén L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart: 2004; 90 12 1483 1484
16. Moutzouri E., Florentin M., Elisaf M. S., Mikhailidis D. P., Liberopoulos E. N. Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension. Curr Vasc Pharmacol: 2010; 8 3 344 362